AA
AlphaCentric Advisors’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-35,000
| Closed | -$998K | – | 249 |
|
|
2024
Q3 | $998K | Sell |
35,000
-1,500
| -4% | -$42.8K | 0.74% | 47 |
|
|
2024
Q2 | $964K | Sell |
36,500
-1,500
| -4% | -$39.6K | 0.71% | 50 |
|
|
2024
Q1 | $1.23M | Hold |
38,000
| – | – | 0.74% | 53 |
|
|
2023
Q4 | $1.6M | Hold |
38,000
| – | – | 1.07% | 31 |
|
|
2023
Q3 | $1.46M | Buy |
+38,000
| New | +$1.46M | 0.83% | 40 |
|
|
2021
Q1 | – | Sell |
-2,150
| Closed | -$99K | – | 216 |
|
|
2020
Q4 | $99K | Hold |
2,150
| – | – | 0.04% | 134 |
|
|
2020
Q3 | $76K | Buy |
2,150
+1,500
| +231% | +$53K | 0.04% | 80 |
|
|
2020
Q2 | $16K | Buy |
+650
| New | +$16K | 0.01% | 126 |
|